<code id='235C4BD991'></code><style id='235C4BD991'></style>
    • <acronym id='235C4BD991'></acronym>
      <center id='235C4BD991'><center id='235C4BD991'><tfoot id='235C4BD991'></tfoot></center><abbr id='235C4BD991'><dir id='235C4BD991'><tfoot id='235C4BD991'></tfoot><noframes id='235C4BD991'>

    • <optgroup id='235C4BD991'><strike id='235C4BD991'><sup id='235C4BD991'></sup></strike><code id='235C4BD991'></code></optgroup>
        1. <b id='235C4BD991'><label id='235C4BD991'><select id='235C4BD991'><dt id='235C4BD991'><span id='235C4BD991'></span></dt></select></label></b><u id='235C4BD991'></u>
          <i id='235C4BD991'><strike id='235C4BD991'><tt id='235C4BD991'><pre id='235C4BD991'></pre></tt></strike></i>

          fashion

          fashion

          author:comprehensive    Page View:3
          Adobe

          It is one of health care’s most vexing quandaries: Patient data must be shared to develop more effective medicines and artificial intelligence tools, but there’s no way to share it without violating privacy and basic data rights.

          Or is there?

          advertisement

          A fresh crop of companies is building a new data economy that enables the shared use of personal health information while enforcing ironclad privacy protections. They are not a monolithic group: each one uses its own methods and technologies, serves different customers, and is motivated by distinct problems and personal philosophies.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Medicare drug price negotiation legal challenge met with skepticism
          Medicare drug price negotiation legal challenge met with skepticism

          AdobeWILMINGTON,Del.—Wednesdaywasthefirsttimethatafederaljudgeaskedquestionsin-personofdrugindustryl

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          Biogen walks away from Aduhelm, years after polarizing approval

          JessicaRinaldi/TheBostonGlobeBiogenisgivingupitsownershipofAduhelm,theAlzheimer’sdiseasetreatmentwho